ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Kymera Therapeutics Inc

Kymera Therapeutics Inc (KYMR)

46.84
-0.12
(-0.26%)
46.84
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
46.84
Bid
45.61
Ask
47.93
Volume
329
0.00 Day's Range 0.00
19.445 52 Week Range 53.27
Market Cap
Previous Close
46.84
Open
-
Last Trade
1
@
45.51
Last Trade Time
04:10:09
Financial Volume
-
VWAP
-
Average Volume (3m)
884,075
Shares Outstanding
65,119,568
Dividend Yield
-
PE Ratio
-13.63
Earnings Per Share (EPS)
-3.44
Revenue
47.07M
Net Profit
-223.86M

About Kymera Therapeutics Inc

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causin... Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Kymera Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KYMR. The last closing price for Kymera Therapeutics was $46.84. Over the last year, Kymera Therapeutics shares have traded in a share price range of $ 19.445 to $ 53.27.

Kymera Therapeutics currently has 65,119,568 shares outstanding. The market capitalization of Kymera Therapeutics is $3.05 billion. Kymera Therapeutics has a price to earnings ratio (PE ratio) of -13.63.

KYMR Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.48-1.0143702451447.3250.2745.7261748847.80303049CS
416.453.87647831830.4450.2728.06118826841.30280718CS
1213.0938.785185185233.7550.2719.44588407533.57808864CS
264.3510.237702988942.4950.2719.44572782834.83701558CS
5213.8441.93939393943353.2719.44561157638.46065491CS
15632.36223.48066298314.4853.279.663220830.83638485CS
26013.9242.284325637932.9291.929.653492534.26332398CS

KYMR - Frequently Asked Questions (FAQ)

What is the current Kymera Therapeutics share price?
The current share price of Kymera Therapeutics is $ 46.84
How many Kymera Therapeutics shares are in issue?
Kymera Therapeutics has 65,119,568 shares in issue
What is the market cap of Kymera Therapeutics?
The market capitalisation of Kymera Therapeutics is USD 3.05B
What is the 1 year trading range for Kymera Therapeutics share price?
Kymera Therapeutics has traded in the range of $ 19.445 to $ 53.27 during the past year
What is the PE ratio of Kymera Therapeutics?
The price to earnings ratio of Kymera Therapeutics is -13.63
What is the cash to sales ratio of Kymera Therapeutics?
The cash to sales ratio of Kymera Therapeutics is 64.79
What is the reporting currency for Kymera Therapeutics?
Kymera Therapeutics reports financial results in USD
What is the latest annual turnover for Kymera Therapeutics?
The latest annual turnover of Kymera Therapeutics is USD 47.07M
What is the latest annual profit for Kymera Therapeutics?
The latest annual profit of Kymera Therapeutics is USD -223.86M
What is the registered address of Kymera Therapeutics?
The registered address for Kymera Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Kymera Therapeutics website address?
The website address for Kymera Therapeutics is www.kymeratx.com
Which industry sector does Kymera Therapeutics operate in?
Kymera Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SLRXSalarius Pharmaceuticals Inc
$ 1.63
(160.76%)
4.74M
VERVVerve Therapeutics Inc
$ 11.26
(79.59%)
482.66k
XTIAXTI Aerospace Inc
$ 4.69
(69.31%)
490.43k
JZJianzhi Education Technology Group Company Ltd
$ 4.60
(60.84%)
96.94k
RGCRegencell Bioscience Holdings Ltd
$ 88.00
(46.67%)
49.15k
LDTCLeddarTech Holdings Inc
$ 0.1522
(-26.26%)
83.03k
RUNSunrun Inc
$ 7.285
(-24.43%)
77.51k
SEDGSolarEdge Technologies Inc
$ 19.38
(-19.18%)
20.47k
SNPXSynaptogenix Inc
$ 3.58
(-16.16%)
1
ENPHEnphase Energy Inc
$ 38.90
(-15.31%)
12.03k
GNLNGreenlane Holdings Inc
$ 0.0107
(-13.71%)
7.51M
SLRXSalarius Pharmaceuticals Inc
$ 1.63
(160.76%)
4.74M
HCTIHealthcare Triangle Inc
$ 0.026
(-1.52%)
2.91M
NCNANuCana PLC
$ 0.1349
(2.82%)
2.06M
GTIGraphjet Technology
$ 0.0856
(11.75%)
1.15M

Your Recent History

Delayed Upgrade Clock